{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"16"}],"units":"Participants"}],"description":"Subjects who were properly monitored for DLTs were to be analyzed to determine the number of subjects with a DLT by dose level.","groups":[{"description":"KW-0761 was administered 4 times at one-week intervals at a dose of 0.01, 0.1, 0.5 or 1.0 mg/kg in patients with CCR4 positive ATL or CCR4 positive PTCL","id":"OG000","title":"KW-0761"}],"paramType":"NUMBER","reportingStatus":"POSTED","timeFrame":"28 days","title":"Incidence of Dose-Limiting Toxicities (DLTs)","type":"PRIMARY","unitOfMeasure":"participants"}